Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. - Topp MS; Matasar M; Allan JN; Ansell SM; Barnes JA; Arnason JE; Michot JM; Goldschmidt N; O'Brien SM; Abadi U; Avivi I; Cheng Y; et al. (Blood, 2025)